Wielosz M, Roncaglioni M C, de Gaetano G, Garattini S
Arch Int Pharmacodyn Ther. 1977 Feb;225(2):232-9.
(+)Fenfluramine decreases the 14C-5HT stored in rat platelets both in in vitro and in in vivo systems, indicating a release of the amine. The effect of (+) fenfluramine in vitro increases by increasing the concentration of the drug, the time of incubation with platelets and the temperature. It is not accompanied by loss of lactate dehydrogenase thus excluding an unspecific damage to the platelet membrane induced by the drug. In addition it is not inhibited either by inhibitors of the uptake of 5HT (chlorimipramine, Lilly 110140) or by inhibitors of the platelet 'release reaction' (acetylsalicylic acid) or by an excess of cold 5HT in the incubation medium. The effect of (+) fenfluramine in vivo is dose-dependent and increases gradually up at least 18 hr after i.p. drug's administration. It is significantly inhibited in rats pretreated by either chlorimipramine or Lilly 110140, but not by acetylsalicyclic acid. In analogy with the effect of (+) fenfluramine on rat brain 5HT, it is suggested that this drug could enter platelets by utilizing the 5HT uptake mechanism, at least in vivo.
(+)芬氟拉明在体外和体内系统中均能降低大鼠血小板中储存的14C-5羟色胺(5HT),表明该胺类物质被释放出来。体外实验中,(+)芬氟拉明的作用随着药物浓度的增加、与血小板孵育时间的延长以及温度的升高而增强。该作用并未伴随乳酸脱氢酶的损失,因此排除了药物对血小板膜的非特异性损伤。此外,5HT摄取抑制剂(氯米帕明、礼来110140)、血小板“释放反应”抑制剂(乙酰水杨酸)或孵育培养基中过量的冷5HT均不能抑制其作用。(+)芬氟拉明的体内作用呈剂量依赖性,腹腔注射给药后至少18小时内作用逐渐增强。氯米帕明或礼来110140预处理的大鼠中,该作用受到显著抑制,但乙酰水杨酸预处理的大鼠中未受抑制。与(+)芬氟拉明对大鼠脑5HT的作用类似,提示该药物至少在体内可通过利用5HT摄取机制进入血小板。